Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Accounts Payables (2016 - 2025)

Prestige Consumer Healthcare has reported Accounts Payables over the past 15 years, most recently at $42.9 million for Q4 2025.

  • Quarterly results put Accounts Payables at $42.9 million for Q4 2025, up 120.17% from a year ago — trailing twelve months through Dec 2025 was $42.9 million (up 120.17% YoY), and the annual figure for FY2025 was $18.9 million, down 51.45%.
  • Accounts Payables for Q4 2025 was $42.9 million at Prestige Consumer Healthcare, up from $41.9 million in the prior quarter.
  • Over the last five years, Accounts Payables for PBH hit a ceiling of $64.3 million in Q4 2022 and a floor of $18.9 million in Q1 2025.
  • Median Accounts Payables over the past 5 years was $41.0 million (2021), compared with a mean of $42.4 million.
  • Peak annual rise in Accounts Payables hit 120.17% in 2025, while the deepest fall reached 51.45% in 2025.
  • Prestige Consumer Healthcare's Accounts Payables stood at $40.1 million in 2021, then soared by 60.22% to $64.3 million in 2022, then plummeted by 38.78% to $39.3 million in 2023, then tumbled by 50.42% to $19.5 million in 2024, then skyrocketed by 120.17% to $42.9 million in 2025.
  • The last three reported values for Accounts Payables were $42.9 million (Q4 2025), $41.9 million (Q3 2025), and $22.2 million (Q2 2025) per Business Quant data.